28
May
Deblistering: current regulatory framework in light of the new opinion issued by the Council of State
In recent years, the practice of deblistering has generated significant debate, largely due to the absence of a uniform national regulatory framework.
28
May
The new tariffs regime and the new Federal Orders by the US Trump administration: first initial thoughts on certain legal and operational impacts for EU pharmaceutical business
President Trump has announced specific tariffs on pharmaceutical products within next weeks.
28
May
Pharmaceuticals and health products purchased online: the processing of user data
The processing of “health data”, given its sensitive nature, can pose significant risks to the rights and fundamental freedoms of data subjects.
28
May
Online sale of drugs: recent trends in EU case law
The promotion and online sale of medicinal products are subject to a series of regulatory provisions and constraints.
28
May
Medical device payback: The Regional Administrative Court of Lazio rejects suppliers’ appeals
In a series of rulings issued in May 2025, the Regional Administrative Court of Lazio dismissed the appeals filed by medical device suppliers challenging the payback mechanism.
28
May
Drug advertising and commercial claims: the Regional Administrative Court of Lazio validates references to format-based savings
Public advertising that emphasizes the greater economic convenience of one over-the-counter drug format over another is considered lawful.
